Browse articles from the EyeWorld December 2022 issue. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.

ASCRS Consensus Statement on VUITY

In August, the Prescribing Information for VUITY (pilocarpine) was updated following a voluntary submission by Allergan to the FDA. This ASCRS Task Force was convened to develop an understanding of the data and a preliminary consensus on appropriate counseling of patients regarding risks associated with the use of Vuity.

Comments Off on ASCRS Consensus Statement on VUITY

A candid conversation about VUITY

With recent case reports showing rare but serious adverse effects with the use of Vuity (pilocarpine, Allergan), EyeWorld spoke with Dagny Zhu, MD, to gain additional insights and perspectives. She commented on the adverse effects, her recommendations for counseling and prescribing, and an off-label use she has found for the product.

Comments Off on A candid conversation about VUITY
Read more about the article Glaucoma in the <em>EyeWorld</em>
Nathan Radcliffe, MD Glaucoma Editor

Glaucoma in the EyeWorld

Glaucoma Editor Nathan Radcliffe, MD, spoke about EyeWorld’s approach to glaucoma management and introduced the new Glaucoma Editor, Manjool Shah, MD.

Comments Off on Glaucoma in the EyeWorld

Review of “IOL power calculations after LASIK or PRK: Barrett True-K biometer-only calculation strategy yields equivalent outcomes as a multiple formula approach”

The Duke University ophthalmology residents review this article from the July issue of the Journal of Cataract & Refractive Surgery.

Comments Off on Review of “IOL power calculations after LASIK or PRK: Barrett True-K biometer-only calculation strategy yields equivalent outcomes as a multiple formula approach”

New IOLs offer option of ‘blended vision’

While the concept of monovision to enhance distance vision in the dominant eye and provide functional near vision in the non-dominant eye is not new, advances in IOL technologies are providing a more coordinated visual experience compared to prior monovision options.

Comments Off on New IOLs offer option of ‘blended vision’